Bell Investment Advisors’s ResMed RMD Stock Holding History

Bell Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.1K	Sell	134 -11	-8%	-$2.28K	﹤0.01%	407
2026 Q1	$32.5K	Sell	145 -8	-5%	-$1.99K	0.01%	330
2025 Q4	$36.9K	Hold	153	–	–	0.01%	290
2025 Q3	$41.9K	Sell	153 -16	-9%	-$4.37K	0.01%	265
2025 Q2	$43.6K	Buy	169 +5	+3%	+$1.19K	0.01%	273
2025 Q1	$36.7K	Hold	164	–	–	0.01%	269
2024 Q4	$37.5K	Sell	164 -6	-4%	-$1.45K	0.01%	257
2024 Q3	$41.5K	Sell	170 -3	-2%	-$670	0.01%	251
2024 Q2	$33.1K	Buy	173 +13	+8%	+$2.64K	0.01%	281
2024 Q1	$31.7K	Buy	160 +7	+5%	+$1.28K	0.01%	286
2023 Q4	$26.3K	Buy	153 +12	+9%	+$1.84K	0.01%	290
2023 Q3	$20.9K	Buy	141 +13	+10%	+$2.35K	﹤0.01%	313
2023 Q2	$28K	Sell	128 -2	-2%	-$446	0.01%	243
2023 Q1	$28.5K	Sell	130 -13	-9%	-$2.82K	0.01%	238
2022 Q4	$29.8K	Buy	143 +20	+16%	+$4.39K	0.01%	234
2022 Q3	$27K	Buy	123 +12	+11%	+$2.73K	0.01%	216
2022 Q2	$23K	Buy	+111	New	+$23.6K	0.01%	240
2021 Q4	$24K	Buy	91 +2	+2%	+$519	0.01%	276
2021 Q3	$23K	Buy	+89	New	+$24.3K	0.01%	258

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bell Investment Advisors's RMD Position: Q2 2026 in Review

Bell Investment Advisors reduced its ResMed (RMD) stake by 7.6% in Q2 2026, selling an estimated $2.28K and leaving 134 shares worth $26.1K. The position accounts for ﹤0.01% of the portfolio, ranked #407.

Bell Investment Advisors first reported a position in RMD in Q3 2021 and has held it in 19 quarters since. The position peaked at $43.6K in Q2 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Bell Investment Advisors held 134 shares of ResMed worth $26.1K as of Q2 2026.
Bell Investment Advisors sold 11 ResMed shares in Q2 2026, an estimated $2.28K.
ResMed made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #407 holding.
Bell Investment Advisors first reported a position in ResMed in Q3 2021 and has held it in 19 quarters since.
Bell Investment Advisors's ResMed position peaked at $43.6K in Q2 2025.
882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.